CTOs on the Move

Bristol-Myers Squibb

www.bms.com

 
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases. Our medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. Through the Bristol-Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world`s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.bms.com
  • 345 Park Avenue
    New York, NY USA 10154
  • Phone: 212.546.4000

Executives

Name Title Contact Details
Aparna Bhalivade
Information Security Officer Profile
Jajati Samal
Director, Cyber Security Profile
Casey Scott
Associate Director, IT Sourcing and Strategic Procurement Profile
Kamayini Kau
Executive. Director of Enterprise Information Strategy and Risk Management and Global Data Protection Officer Profile
Miguel Crespo
Head of Cyber Advisory Profile

Jobs

Head of Global Talent Acquisition

Bristol-Myers Squibb Princeton, NJ
Job Description

The Head Global Talent Acquisition will report to the Head of Global Talent and Organizational Effectiveness who reports to the company’s Chief Human Resources Officer. The incumbent will lead a global team of 30+ BMS individuals and 110+ recruitment professionals working for Cielo (US) and Alexander Mann ...

Funding

Bristol-Myers Squibb raised $20.2M on 12/17/2020

Similar Companies

NapaJen

A pioneer in immuno-modulation by cell specific delivery of oligonucleotide drugs to antigen presenting cells completing IND enabling studies for a groundbreaking anti-GVHD drug for hematopoietic stem cell transplantation in hematological cancers.

Du Pont Pharmaceuticals Co

Du Pont Pharmaceuticals Co is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Angion

Angion Biomedica Corp. is a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Angion`s lead product candidate, ANG-3777, is a small molecule designed to mimic the biological activity of hepatocyte growth factor (HGF) to activate the HGF/c-Met pathway, which has a central role in tissue repair and organ recovery. Enrollment is ongoing in a placebo-controlled Phase 3 registration trial examining the efficacy of ANG-3777 in reducing the severity of transplant-associated acute kidney injury, also known as delayed graft function, in patients at risk for kidney dysfunction. ANG-3777 is also in a Phase 2 clinical trial for the treatment of acute kidney injury associated with cardiac surgery involving cardiopulmonary bypass. Angion is also developing ANG-3070, an orally-bioavailable small molecule, as a potential treatment for a variety of chronic fibrotic diseases sharing similar underlying disease-driving pathways identified and targeted using a precision-medicine approach.

Vesigen Therapeutics

Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology.

Qvin

Take control of your health in the most natural way possible.